 Connection
Hitoshi Irabu to Dermatomyositis
This is a "connection" page, showing publications Hitoshi Irabu has written about Dermatomyositis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.909 |
|
|
|
-
Irabu H, Ohara A, Nakamura A, Narazaki H, Hayashi Y, Yamasaki Y, Iwata N, Ohshima S, Nishiyama S, Nakagishi Y, Fukuhara D, Ishida H, Goto M, Hashimoto K, Yasuoka R, Nozawa T, Miyamae T, Umebayashi H, Mori M, Shimizu M. Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosus. Mod Rheumatol. 2026 Mar 05; 36(2):239-245.
Score: 0.238
-
Kaneko S, Mizuta M, Hatano M, Shimbo A, Irabu H, Yatabe R, Akamine K, Sugita Y, Hashimoto K, Yamasaki Y, Nakagishi Y, Mori M, Takagi M, Shimizu M. Distinct cytokine signature in juvenile dermatomyositis: linking myositis-specific antibodies and clinical manifestations. Cytokine. 2026 Jan; 197:157070.
Score: 0.233
-
Shimbo A, Kaneko S, Irabu H, Akutsu Y, Hayashi Y, Mouri M, Yamazaki S, Mori M, Shimizu M. Efficacy of hydroxychloroquine treatment for the skin manifestations of juvenile dermatomyositis. Mod Rheumatol Case Rep. 2025 07 25; 9(2).
Score: 0.229
-
Yamazaki S, Shimizu M, Yakabe A, Inage E, Jimbo K, Suzuki M, Miyaoka F, Kaneko S, Irabu H, Shimbo A, Ohtomo Y, Mori M, Morio T, Shimizu T. Successful treatment with tofacitinib for anti-melanoma differentiation-associated gene 5 antibody-positive juvenile dermatomyositis: case reports and review of the literature. Immunol Med. 2024 Jun; 47(2):110-117.
Score: 0.209
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|